Project Grant R03TR005626

Award Date 6/17/25
Completion Date 5/31/26
Dollars Obligated $156K
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Delaware, USA
Similar Awards
This Project Grant award from the National Science Foundation's Biological Sciences program (CFDA 47.074) provides $999,999.00 in funding to Emory University to study the function of epigenetic memory in cell fate determination and behavior. The research aims to uncover how altered chromatin structure can serve as heritable, transgenerational information and how defects in transcription caused by misregulation of histone methylation can actively influence behavior. The project will leverage...
This $1,555,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research to understand the cellular mechanisms regulating mitochondrial DNA (mtDNA) heteroplasmy and quality control. The research team at the University of Washington will use cutting-edge single-cell and ultra-high accuracy sequencing techniques to investigate how mitochondrial quality control processes influence...
This $1,000,000 four-year Project Grant from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) will fund research at Northeastern University exploring the role of mitochondria in regulating cell fate decisions during early mammalian development. Specifically, the researchers will test the hypothesis that differential allocation of mitochondrial subtypes, which vary in biochemical properties and protein content including levels of the transcription factor TEAD4,...
This Project Grant award of $198,750.00 from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) will be used by the University of Texas at Austin to develop conditional animal models for studying mitochondrial diseases. The goal is to establish a toolkit to enable precise CRISPR-based editing of the mitochondrial genome, which will facilitate the study of different pathogenic mitochondrial DNA variations and provide insights into the underlying mechanisms of...
The University of California, San Diego will receive $2,844,000 under a three-year Project Grant from the Department of Health and Human Services' National Institute of General Medical Sciences to develop tools and models to decode mitochondrial morphology dynamics and predict cell fate decisions. The grant funds research from September 2022 to August 2025 under the Biomedical Research and Research Training program (CFDA 93.859). Specifically, the University will expand its prototype...
The National Institute of Child Health and Human Development (NICHD) awarded a $149,804 Project Grant under CFDA 93.865 (Child Health and Human Development Extramural Research) to Duke University to conduct research on the role of mitochondrial specialization in early embryonic development. The grant, awarded on September 1, 2025, supports the development of C. elegans as a model system to understand how mitochondrial electron transport chain (ETC) levels are regulated to meet the varying...
This National Science Foundation (NSF) Project Grant under the Biological Sciences program (CFDA 47.074) provides $1,199,999.00 in funding to the University of Southern California (USC) to study the molecular mechanisms of DNA N6-adenine methylation (6mA) in eukaryotes. The project uses the unicellular eukaryote Tetrahymena thermophila as a model system, employing advanced DNA sequencing techniques to map 6mA across the genome and elucidate how this DNA modification is involved in gene...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $1,570,000.00 to Rutgers, The State University to conduct research on RNA-mediated chromatin regulation and transgenerational epigenetic inheritance in C. elegans. The key objectives of this 5-year project are to: 1) investigate the function and enzymology of the novel histone modification H3K23me3, which is involved...
This $999,996 Project Grant award, provided by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports fundamental research aimed at generating "designer mitochondria" for biotechnology, healthcare, and basic research applications. The key objectives are to identify the factors required for human mitochondrial DNA (mtDNA) replication and characterize the mechanisms underlying the species-specificity of this process. This work represents a critical step...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to improve understanding of the role of genetic variation in mitochondrial-nuclear dynamics and their impact on organismal health. The $399,766 award, effective January 1, 2025 through December 31, 2026, will leverage specific populations of threespine stickleback fish to study how the nuclear genome evolves and adapts to maintain mitochondrial genome variation. The project will fill...

This Project Grant award from the National Center for Advancing Translational Sciences (CFDA 93.350) is funding research at the University of Delaware to investigate the impact of the histone methyltransferase MET-2 (the C. elegans homolog of human SETDB1) on mitochondrial morphology, function, and protein abundance. The $155,559 award, effective June 17, 2025 through May 31, 2026, will utilize genome-edited C. elegans strains, advanced imaging, and quantitative proteomics to define MET-2's effects on mitochondria. The goal is to better understand how altered SETDB1 activity contributes to the pathogenesis of rare diseases like Huntington's, Duchenne muscular dystrophy, acute myeloid leukemia, and mesothelioma where mitochondrial dysfunction is a key factor. This basic science research could have significant impact on translating these findings to improve treatments for these conditions.

Generated 7/1/25, 2:17 AM